Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in

Guardant Health Inc
XETRA:5GH

Watchlist Manager
Guardant Health Inc Logo
Guardant Health Inc
XETRA:5GH
Watchlist
Price: 50.22 EUR 0.04% Market Closed
Market Cap: €5.1B
Write Note Create Alert Ask AI

Wall St Price Targets

5GH Price Targets Summary
Guardant Health Inc

Wall Street analysts forecast 5GH stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 5GH is 44.58 EUR with a low forecast of 27.9 EUR and a high forecast of 59.64 EUR.

5GH Lowest Forecast
27.9 EUR
-44% Downside
5GH Average Forecast
44.58 EUR
-11% Downside
5GH Highest Forecast
59.64 EUR
19% Upside
Lowest Forecast
Price Target
27.9 EUR
44% Downside
Average Forecast
Price Target
44.58 EUR
11% Downside
Highest Forecast
Price Target
59.64 EUR
19% Upside
Guardant Health Inc Competitors:
Price Targets
S
SRFM
Surf Air Mobility Inc
421% Upside
BLFS
BioLife Solutions Inc
17% Upside
SIGI
Selective Insurance Group Inc
-6% Downside
PHVS
Pharvaris NV
41% Upside
S
SRFM
Surf Air Mobility Inc
421% Upside
BLFS
BioLife Solutions Inc
17% Upside
SIGI
Selective Insurance Group Inc
-6% Downside
PHVS
Pharvaris NV
41% Upside

Revenue
Forecast

45% / Year
Past Growth
32% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
45% / Year
Past Growth
32% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 8 years, the compound annual growth rate for Revenue has been 45%. The projected CAGR for the next 3 years is 32%.

What are analyst estimates?

Gross Profit
Forecast

56% / Year
Past Growth
32% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
56% / Year
Past Growth
32% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 8 years, the compound annual growth rate for Gross Profit has been 56%. The projected CAGR for the next 3 years is 32%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
9%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
9%
Average Beat

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

What are analyst estimates?

Continue 5GH Research

Summary
5GH intrinsic value, competitors valuation, and company profile.
DCF Valuation
5GH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
5GH stock valuation using valuation multiples.
Wall St Estimates
5GH price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
5GH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Guardant Health Inc listings:
NASDAQ • USD
GH
 F • EUR
5GH
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 5GH's stock price target?
Price Target
44.58 EUR

According to Wall Street analysts, the average 1-year price target for 5GH is 44.58 EUR with a low forecast of 27.9 EUR and a high forecast of 59.64 EUR.

What is the Revenue forecast for Guardant Health Inc?
Projected CAGR
32%

Over the last 8 years, the compound annual growth rate for Revenue has been 45%. The projected CAGR for the next 3 years is 32%.

What is the Gross Profit forecast for Guardant Health Inc?
Projected CAGR
32%

Over the last 8 years, the compound annual growth rate for Gross Profit has been 56%. The projected CAGR for the next 3 years is 32%.

Back to Top
ALPHA SPREAD
Follow us
Join 346,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett